However, whether Rh2 can exerts inhibitory effects over HDACs in HepG2 liver cancer cells and HepG2 cell-derived xenograft tumors and subsequently regulate the expression of downstream MAPK signal pathway and tumor angiogenesis remains to be determined. This evidence concerns the gene RHAG and neoplasm.